These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1656654

  • 1. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H, Heytmanek H, Kurz C, Metka M.
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [Abstract] [Full Text] [Related]

  • 2. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
    Bonduki CE, Lourenço DM, Baracat E, Haidar M, Noguti MA, da Motta EL, Lima GR.
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
    Sajtos B, Herold J, Winkler UH, Schindler AE.
    Zentralbl Gynakol; 1995 Mar; 117(10):524-30. PubMed ID: 7491835
    [Abstract] [Full Text] [Related]

  • 4. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE.
    Zentralbl Gynakol; 1995 Mar; 117(10):504-7. PubMed ID: 7491831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F, Marziani R, Perniola G, Ebano V, Fruscella M, Mossa B.
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hormone substitution therapy. Side-effects and compliance of various therapeutic regimens].
    Perrone G, Barillaro F, Bazzoffi R, Capri O, Critelli C, Galoppi P, Grande S, Santoro G.
    Minerva Ginecol; 1999 Mar; 51(3):53-8. PubMed ID: 10352534
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Changes in AT-III following hormone therapy of females in the climacteric].
    Enzelsberger H, Heytmanek G, Kurz C, Metka M.
    Gynakol Rundsch; 1989 Jan; 29 Suppl 2():422-4. PubMed ID: 2613068
    [No Abstract] [Full Text] [Related]

  • 20. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK, Coglan MJ, Wright GR, DeVoss KN, Battistutta D.
    Med J Aust; 1998 Mar 02; 168(5):216-20. PubMed ID: 9539899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.